Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Stuttgart - Delayed Quote EUR

Viking Therapeutics Inc (1VT.SG)

Compare
27.36
-0.54
(-1.94%)
As of 4:42:48 PM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
150,921
150,921
100,827
70,355
55,682
Operating Income
-150,921
-150,921
-100,827
-70,355
-55,682
Net Non Operating Interest Income Expense
40,846
40,846
14,932
1,530
685
Other Income Expense
112
112
--
-42
7
Pretax Income
-109,963
-109,963
-85,895
-68,867
-54,990
Net Income Common Stockholders
-109,963
-109,963
-85,895
-68,867
-54,990
Diluted NI Available to Com Stockholders
-109,963
-109,963
-85,895
-68,867
-54,990
Basic EPS
-1.01
-1.01
-0.91
-0.90
-0.71
Diluted EPS
-1.01
-1.01
-0.91
-0.90
-0.71
Basic Average Shares
109,037.12
109,037.12
94,347
76,834
77,198
Diluted Average Shares
109,037.12
109,037.12
94,347
76,834
77,198
Total Operating Income as Reported
-150,921
-150,921
-100,827
-70,355
-55,682
Total Expenses
150,921
150,921
100,827
70,355
55,682
Net Income from Continuing & Discontinued Operation
-109,963
-109,963
-85,895
-68,867
-54,990
Normalized Income
-110,075
-110,075
-85,895
-68,825
-54,997
Interest Income
40,940
40,940
15,020
1,589
703
Net Interest Income
40,846
40,846
14,932
1,530
685
EBIT
-150,921
-150,921
-100,827
-70,355
-55,682
EBITDA
-150,575
-150,575
-100,535
-70,064
-55,386
Reconciled Depreciation
346
346
292
291
296
Net Income from Continuing Operation Net Minority Interest
-109,963
-109,963
-85,895
-68,867
-54,990
Total Unusual Items Excluding Goodwill
112
112
--
-42
7
Total Unusual Items
112
112
--
-42
7
Normalized EBITDA
-150,687
-150,687
-100,535
-70,022
-55,393
12/31/2021 - 8/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

W2J.F Carisma Therapeutics, Inc.
0.3784
-4.01%
 
S09.BE Sutro Biopharma Inc
1.4700
-2.65%
 
W2J.SG CARISMA Therapeutics Inc
0.3846
-0.41%
 
S09.MU Sutro Biopharma Inc
1.5200
-3.18%
 
0M4.BE Mersana Therapeutics Inc
0.4744
-0.94%
 
S09.F Sutro Biopharma, Inc.
1.4700
-2.00%
 
0M4.F Mersana Therapeutics, Inc.
0.3900
-9.87%
 
0M4.MU Mersana Therapeutics Inc
0.4915
-5.15%
 
CYCCP Cyclacel Pharmaceuticals, Inc.
7.06
+1.58%
 
BLRX.TA BioLineRx Ltd.
2.0000
-4.76%